Cosmax Inc (192820) - Total Liabilities
Based on the latest financial reports, Cosmax Inc (192820) has total liabilities worth ₩1.55 Trillion KRW (≈ $1.05 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 192820 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cosmax Inc - Total Liabilities Trend (2014–2024)
This chart illustrates how Cosmax Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 192820 total asset value.
Cosmax Inc Competitors by Total Liabilities
The table below lists competitors of Cosmax Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥2.80 Billion |
|
Bausch Health Companies Inc
TO:BHC
|
Canada | CA$25.60 Billion |
|
Keboda Technology Co Ltd
SHG:603786
|
China | CN¥3.01 Billion |
|
Pandox AB (publ)
ST:PNDX-B
|
Sweden | Skr78.83 Billion |
|
AQ Group AB
ST:AQ
|
Sweden | Skr2.33 Billion |
|
CPI Europe AG
VI:CPI
|
Austria | €4.99 Billion |
|
Aker Solutions ASA
OL:AKSO
|
Norway | Nkr25.82 Billion |
|
Empresas Cablevisión S.A.B. de C.V
MX:CABLECPO
|
Mexico | MX$9.44 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Cosmax Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 192820 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cosmax Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cosmax Inc (2014–2024)
The table below shows the annual total liabilities of Cosmax Inc from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩1.42 Trillion ≈ $965.64 Million |
+18.89% |
| 2023-12-31 | ₩1.20 Trillion ≈ $812.22 Million |
+25.87% |
| 2022-12-31 | ₩952.20 Billion ≈ $645.30 Million |
+0.60% |
| 2021-12-31 | ₩946.54 Billion ≈ $641.46 Million |
+3.21% |
| 2020-12-31 | ₩917.14 Billion ≈ $621.53 Million |
+3.30% |
| 2019-12-31 | ₩887.88 Billion ≈ $601.70 Million |
+8.32% |
| 2018-12-31 | ₩819.69 Billion ≈ $555.50 Million |
+16.16% |
| 2017-12-31 | ₩705.63 Billion ≈ $478.20 Million |
+53.87% |
| 2016-12-31 | ₩458.60 Billion ≈ $310.79 Million |
+33.93% |
| 2015-12-31 | ₩342.41 Billion ≈ $232.05 Million |
+39.66% |
| 2014-12-31 | ₩245.17 Billion ≈ $166.15 Million |
-- |
About Cosmax Inc
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, … Read more